Compare ABCL & LPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ABCL | LPG |
|---|---|---|
| Founded | 2012 | 2013 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Marine Transportation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.5B |
| IPO Year | 2020 | 2014 |
| Metric | ABCL | LPG |
|---|---|---|
| Price | $5.97 | $39.69 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 3 |
| Target Price | $8.40 | ★ $39.33 |
| AVG Volume (30 Days) | ★ 6.2M | 699.1K |
| Earning Date | 05-11-2026 | 05-21-2026 |
| Dividend Yield | N/A | ★ 8.26% |
| EPS Growth | 10.91 | ★ 112.15 |
| EPS | N/A | ★ 4.54 |
| Revenue | $75,128,000.00 | ★ $481,511,242.00 |
| Revenue This Year | N/A | $35.73 |
| Revenue Next Year | $21.85 | N/A |
| P/E Ratio | ★ N/A | $8.79 |
| Revenue Growth | ★ 160.56 | 36.27 |
| 52 Week Low | $2.75 | $23.76 |
| 52 Week High | $6.79 | $48.12 |
| Indicator | ABCL | LPG |
|---|---|---|
| Relative Strength Index (RSI) | 60.46 | 43.24 |
| Support Level | $5.23 | $24.30 |
| Resistance Level | $6.65 | $45.23 |
| Average True Range (ATR) | 0.52 | 1.67 |
| MACD | -0.01 | -0.51 |
| Stochastic Oscillator | 56.38 | 18.28 |
AbCellera Biologics Inc is a clinical-stage biotechnology company focused on discovering and developing first-in-class antibody medicines for indications with high unmet medical need. It has built a platform for advancing antibody drug programs that the company believes provides it with a competitive advantage in addressing challenging, high-value targets such as complex transmembrane proteins and novel modalities, including multispecifics and antibody-drug conjugates. Organisation's pipeline includes two drug candidates in clinical development, two development candidates in Investigational New Drug (IND/Clinical Trial Application (CTA)-enabling activities, and more than 20 active discovery programs across multiple modalities and indications.
Dorian LPG Ltd is an international liquefied petroleum gas shipping company focused on owning and operating gas carriers, or VLGCs. The company currently owns and operates around 22 modern VLGCs, including nineteen new fuel-efficient 84,000 cbm ECO-design VLGCs. Dorian LPG has offices in Connecticut, USA, London, United Kingdom, and Athens, Greece. IT operates in one reportable segment, the international transportation of LPG.